In MASLD, multiple pathways, such as death receptors, autophagy‐related proteins, GSDMD, and hypoxia‐inducible factor 2α (HIF‐2α), are all involved in the initiation and progression of the disease. Here, EPAS1 is linked to metabolic dysfunction-associated steatotic liver disease.